Features By Alisa Roth
Pages
0
Grim holiday greetings from GM?
The Detroit News reports that GM, whose shares hit new lows this week, will announce a series of plant closures before Thanksgiving. Word is, they could eliminate at least 25,000 jobs. Alisa Roth has more.
0
Made in China
Many business leaders are calling for restrictions on Chinese imports to create more demand for US goods. Alisa Roth chronicles what would happen to her morning routine if all her belongings made in China suddenly disappeared.
0
A day without China
A quarter of everything we import comes from China, most of it consumer goods. To see just how much a part of our daily lives China's goods are, we decided to try and spend a day without them. Alisa Roth has more from New York.
0
Wal-Mart protest
A grass-roots organization has launched a campaign to keep tabs of how Wal-Mart impacts local communities throughout the country. Alisa Roth reports.
0
US: China's not playing fair
A report out today from a congressional advisory committee suggests Congress might want to take another look at China's energy use. Alisa Roth has more from New York.
0
Tussle at the NYSE
Dissident groups are attempting to forestall NYSE's efforts to acquire Archipelago electronic trading company. Alisa Roth reports.
0
Big money in the Big Apple
Michael Bloomberg is coasting to a likely landslide victory today over his challenger for mayor. Alisa Roth reports on how the mayor's vast personal wealth factored into his re-election efforts.
0
Vertical integration vertigo
Warner Bros. will lay off about 5% of its movie and TV workforce due to slow DVD sales. Time Warner, meanwhile, saw third-quarter earnings rise 80%. But wait, there's more. Alisa Roth reports from New York.
0
New Orleans levees in the spotlight
The Senate Homeland Security and Governmental Affairs Committee hears expert testimony Wednesday about why the levees protecting New Orleans failed during Hurricane Katrina. Alisa Roth reports.
0
Novartis buys Chiron
Pharmaceutical companies have been working to come up with vaccines and drugs to treat the bird flu. But it may a more pedestrian influenza that are guiding their business decisions. Alisa Roth has more.
Pages
